Research Collaboration Project on Anti-LL37 Autoantibodies in Psoriatic Arthritis Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025565

Enrollment

300

Registered

2021-06-17

Start date

2021-10-18

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M07 M05

Interventions

Group 1: from July recruiting the blood samples in the MVZ, from then start to research from Phadia Group 2: controlls: 1) Pat. with Rheumatoid Arthritis 2) Pat. with Osteoarthritis

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: all patients with an psoriatic Arthritis (EULAR conform), or as controlls (Rheumatoid Arthritis, Osteoarthritis [EULAR conform])

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Range of approx. 300 Patients	—

Countries

Germany

Contacts

Public ContactDaniel Vagedes

MVZ Rheumatologie

daniel.vagedes@mvz-klinikum-straubing.de09421-710-7620

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026